CEN Biotech Inc. Notice to Shareholders
(firmenpresse) - LAKESHORE, ON -- (Marketwired) -- 09/14/16 -- Bill Chaaban, President & CEO of CEN Biotech Inc., a specialty pharmaceutical company, provides the following Shareholder Update:
On September 13, 2016, the unauthorized and potentially illegal trading of our company stock took place under the ticker CENBF. Although we applied for our ticker symbol, it should not have been issued without a successful 15c211 filing or the completion of our s-1.
IT IS IMPORTANT TO CLARIFY that
As our shareholders know based on a prior press release, our 15c211 was not approved by the Securities and Exchange Commission. As such, we are seeking to file an s-1 to register our company's securities.
To date, the s-1 has NOT been filed with the SEC, It is currently being reviewed by our legal counsel.
Thank you for your attention to this extremely important matter.
CEN Biotech, Inc.
Bill Chaaban
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.09.2016 - 15:05 Uhr
Sprache: Deutsch
News-ID 494790
Anzahl Zeichen: 0
contact information:
Town:
LAKESHORE, ON
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 292 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CEN Biotech Inc. Notice to Shareholders"
steht unter der journalistisch-redaktionellen Verantwortung von
CEN Biotech Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
